{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:22:40Z","timestamp":1785842560292,"version":"3.56.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1106,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41379-019-0370-1","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T18:25:25Z","timestamp":1569522325000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions"],"prefix":"10.1016","volume":"33","author":[{"given":"Na-Yi Yuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Shun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang-Yuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0370-1_bib1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/cncr.21310","article-title":"Ovarian cancer: can we make the clinical diagnosis earlier?","volume":"104","author":"Smith","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib2","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-019-0370-1_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib5","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/s41379-019-0370-1_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2013a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/aje\/kwp314","article-title":"Risk factors for epithelial ovarian cancer by histologic subtype","volume":"171","author":"Gates","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib10","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2006.06.088","article-title":"Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies","volume":"196","author":"Pelucchi","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u201cIncessant ovulation\u201d and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/s41379-019-0370-1_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.10927","article-title":"Ovulation and risk of epithelial ovarian cancer","volume":"104","author":"Purdie","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","article-title":"Ovarian cancer: epidemiology, biology, and prognostic factors","volume":"19","author":"Holschneider","year":"2000","journal-title":"Semin surgical Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.10696","article-title":"Long-term effects of oral contraceptives on ovarian cancer risk","volume":"102","author":"Bosetti","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajog.2004.03.035","article-title":"Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis","volume":"191","author":"Modugno","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib18","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception","volume":"190","author":"Burkman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/EDE.0b013e31816334c5","article-title":"Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects","volume":"19","author":"Lurie","year":"2008","journal-title":"Epidemiology"},{"key":"10.1038\/s41379-019-0370-1_bib21","doi-asserted-by":"crossref","unstructured":"Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development.The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Eng J Med. 1987;316:650\u20135.","DOI":"10.1056\/NEJM198703123161102"},{"key":"10.1038\/s41379-019-0370-1_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.2910280602","article-title":"Incidence of ovarian cancer in relation to the use of oral contraceptives","volume":"28","author":"Weiss","year":"1981","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a117296","article-title":"Parity, contraception, infertility, and the risk of epithelial ovarian cancer","volume":"140","author":"Risch","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.fertnstert.2004.03.013","article-title":"Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study","volume":"82","author":"Pike","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1038\/s41379-019-0370-1_bib25","first-page":"32","article-title":"Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer. International journal of gynecological cancer: official journal of the International Gynecological Cancer","volume":"17","author":"Yang","year":"2007","journal-title":"Society"},{"key":"10.1038\/s41379-019-0370-1_bib26","doi-asserted-by":"crossref","unstructured":"Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Ame J Epidemiol. 1992;136:1184\u2013203.","DOI":"10.1093\/oxfordjournals.aje.a116427"},{"key":"10.1038\/s41379-019-0370-1_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","article-title":"Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies","volume":"83","author":"Riman","year":"2004","journal-title":"Acta Obst Gynecol Scand"},{"key":"10.1038\/s41379-019-0370-1_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0090-8258(03)00088-X","article-title":"Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population","volume":"89","author":"Yen","year":"2003","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib30","first-page":"711","article-title":"Determinants of ovarian cancer risk. I. Reproductive experiences and family history","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-019-0370-1_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910620606","article-title":"Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. International journal of cancer","volume":"62","author":"Purdie","year":"1995","journal-title":"J Int Cancer"},{"key":"10.1038\/s41379-019-0370-1_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0895-4356(90)90160-Q","article-title":"Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer","volume":"43","author":"Gwinn","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1038\/s41379-019-0370-1_bib34","doi-asserted-by":"crossref","unstructured":"Bell D,\u00a0Berchuck A,\u00a0Birrer M,\u00a0Chien J,\u00a0Cramer D,\u00a0Dao F,\u00a0et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","DOI":"10.1038\/nature10166"},{"key":"10.1038\/s41379-019-0370-1_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ebiom.2019.01.061","article-title":"IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation","volume":"41","author":"Hsu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1038\/s41379-019-0370-1_bib36","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1073\/pnas.1017213108","article-title":"Reactive oxygen species are indispensable in ovulation","volume":"108","author":"Shkolnik","year":"2011","journal-title":"PNAS"},{"key":"10.1038\/s41379-019-0370-1_bib37","doi-asserted-by":"crossref","unstructured":"Huang HS, Hsu CF, Chu SC, Chen PC, Ding DC, Chang MY, et al. Haemoglobin in pelvic fluid rescues fallopian tube epithelial cells from ROS stress and apoptosis. J Pathol. 2016;240:484\u201394.","DOI":"10.1002\/path.4807"},{"key":"10.1038\/s41379-019-0370-1_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1038\/s41379-019-0370-1_bib39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00001648-200003000-00005","article-title":"Beyond ovulation: oral contraceptives and epithelial ovarian cancer","volume":"11","author":"Siskind","year":"2000","journal-title":"Epidemiology"},{"key":"10.1038\/s41379-019-0370-1_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2006.03.046","article-title":"Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk","volume":"103","author":"Maxwell","year":"2006","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.2012.03298.x","article-title":"Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study","volume":"119","author":"Wilailak","year":"2012","journal-title":"BJOG"},{"key":"10.1038\/s41379-019-0370-1_bib43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1365-2648.1990.tb01981.x","article-title":"The pill and cancer: a review of the literature. A case of swings and roundabouts?","volume":"15","author":"Knowlden","year":"1990","journal-title":"J Adv Nurs"},{"key":"10.1038\/s41379-019-0370-1_bib44","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","article-title":"Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study","volume":"9","author":"Urban","year":"2012","journal-title":"PLoS Med"},{"key":"10.1038\/s41379-019-0370-1_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1038\/s41379-019-0370-1_bib46","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib47","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-019-0370-1_bib48","first-page":"42","article-title":"Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive","volume":"12","author":"Whiteman","year":"2003","journal-title":"Oncology"},{"key":"10.1038\/s41379-019-0370-1_bib49","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwn006","article-title":"Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women","volume":"167","author":"Moorman","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib50","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","article-title":"Parity, age at first childbirth, and risk of ovarian cancer","volume":"344","author":"Adami","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib51","first-page":"397","article-title":"Pregnancy recency and risk of ovarian cancer","volume":"10","author":"Cooper","year":"1999","journal-title":"Cancer Causes Control"},{"key":"10.1038\/s41379-019-0370-1_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J surgical Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","article-title":"Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer","volume":"89","author":"Schildkraut","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-019-0370-1_bib59","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib60","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","article-title":"Progesterone prevents high-grade serous ovarian cancer by inducing necroptosis of p53-defective fallopian tube epithelial cells","volume":"18","author":"Wu","year":"2017","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-019-0370-1_bib61","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1471-0528.1984.tb15086.x","article-title":"Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration","volume":"91","author":"Ottoson","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1038\/s41379-019-0370-1_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17565-x","article-title":"Endometrial apoptosis and neutrophil infiltration during menstruation exhibits spatial and temporal dynamics that are recapitulated in a mouse model","volume":"7","author":"Armstrong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1038\/s41379-019-0370-1_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J surgical Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib64","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk factors for a serous cancer precursor (\u201cp53 signature\u201d) in women with inherited BRCA mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecologic Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/PGP.0000000000000179","article-title":"Immunophenotypic analysis in early mullerian serous carcinogenesis","volume":"34","author":"Nafisi","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib67","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1073\/pnas.96.10.5722","article-title":"Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells","volume":"96","author":"Lau","year":"1999","journal-title":"PNAS"},{"key":"10.1038\/s41379-019-0370-1_bib68","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an ovarian tumor tissue analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-019-0370-1_bib69","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0370-1_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJWH.S129493","article-title":"Effect of menopause on hormonal receptors in ampullae of the fallopian tube with a special reference to the p53 signature","volume":"9","author":"Urabe","year":"2017","journal-title":"Int J Women's Health"},{"key":"10.1038\/s41379-019-0370-1_bib71","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwi162","article-title":"Short-term oral contraceptive use and the risk of epithelial ovarian cancer","volume":"162","author":"Greer","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0370-1_bib73","doi-asserted-by":"crossref","first-page":"e1000114","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med"},{"key":"10.1038\/s41379-019-0370-1_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1038\/s41379-019-0370-1_bib75","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0370-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:42:54Z","timestamp":1760229774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222009425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0893395222009425"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0370-1","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0370-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}